Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: External surface coil vs. endorectal surface coil

被引:31
作者
Kaji, Y
Wada, A
Imaoka, I
Matsuo, M
Terachi, T
Kobashi, Y
Sugimura, K
Fujii, M
Maruyama, K
Takizawa, O
机构
[1] Kobe Univ, Sch Med, Dept Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Tenri Hosp, Dept Radiol, Div MR Imaging, Tenri, Nara 632, Japan
[3] Tenri Hosp, Dept Urol, Tenri, Nara 632, Japan
[4] Tenri Hosp, Dept Pathol, Tenri, Nara 632, Japan
[5] Siemens Asahi Med Technol Ltd, Mkt Div, Tokyo, Japan
关键词
magnetic resonance (MR); spectroscopy; coils; prostate; MR; neoplasms; chemical shift imaging;
D O I
10.1002/jmri.10204
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To compare the diagnostic ability of proton magnetic resonance spectroscopy (MRS) using an external surface coil with that using an endorectal surface coil in patients with Prostate cancer. Materials and Methods: MR imaging (MRI) and two-dimensional chemical shift imaging (2D CSI) were performed in 5 healthy volunteers and in 35 patients with prostate cancer. The receiver coil was the anterior lower part of a phased-array coil or an endorectal surface coil. Results: Receiver-operating characteristic analysis for diagnosing prostate cancer showed no significant difference (P = 0.784) between the area under the curve of phase array coil CSI and that of endorectal surface coil CSI. Conclusion: The phased-array coil CSI could provide comparable detection accuracy to endorectal surface coil CSI. In patients with rectal diseases or patients who could not tolerate the discomfort with insertion of an endorectal surface coil, we recommend the phased-array coil CSI.
引用
收藏
页码:697 / 706
页数:10
相关论文
共 16 条
[1]  
*41 WORLD MED ASS, 1990, B PAN AM HLTH ORG, V24, P606
[2]   MULTISECTION PROTON MR SPECTROSCOPIC IMAGING OF THE BRAIN [J].
DUYN, JH ;
GILLEN, J ;
SOBERING, G ;
VANZIJL, PCM ;
MOONEN, CTW .
RADIOLOGY, 1993, 188 (01) :277-282
[3]   Localizing prostate cancer in the presence of postbiopsy changes on MR images: Role of proton MR spectroscopic imaging [J].
Kaji, Y ;
Kurhanewicz, J ;
Hricak, H ;
Sokolov, DL ;
Huang, LR ;
Nelson, SJ ;
Vigneron, DB .
RADIOLOGY, 1998, 206 (03) :785-790
[4]   In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: Localized proton magnetic resonance spectroscopy using external-body surface coil [J].
Kim, JK ;
Kim, DY ;
Lee, YH ;
Sung, NK ;
Chung, DS ;
Kim, OD ;
Kim, KB .
MAGNETIC RESONANCE IMAGING, 1998, 16 (10) :1281-1288
[5]   Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.1-cm(3)) spatial resolution [J].
Kurhanewicz, J ;
Vigneron, DB ;
Hricak, H ;
Narayan, P ;
Carroll, P ;
Nelson, SJ .
RADIOLOGY, 1996, 198 (03) :795-805
[6]   The prostate: MR imaging and spectroscopy - Present and future [J].
Kurhanewicz, J ;
Vigneron, DB ;
Males, RG ;
Swanson, MG ;
Yu, KK ;
Hricak, H .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2000, 38 (01) :115-+
[7]   Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age-related differences [J].
Lowry, M ;
Liney, GP ;
Turnbull, LW ;
Manton, DJ ;
Blackband, SJ ;
Horsman, A .
MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (03) :352-358
[8]   ZONAL DISTRIBUTION OF PROSTATIC ADENOCARCINOMA - CORRELATION WITH HISTOLOGIC PATTERN AND DIRECTION OF SPREAD [J].
MCNEAL, JE ;
REDWINE, EA ;
FREIHA, FS ;
STAMEY, TA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (12) :897-906
[9]  
SALIBI N, 1998, CLIN SPECTROSCOPY 1, P62
[10]   Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study [J].
Scheidler, J ;
Hricak, H ;
Vigneron, DB ;
Yu, KK ;
Sokolov, DL ;
Huang, LR ;
Zaloudek, CJ ;
Nelson, SJ ;
Carroll, PR ;
Kurhanewicz, J .
RADIOLOGY, 1999, 213 (02) :473-480